SlideShare una empresa de Scribd logo
1 de 7
Descargar para leer sin conexión
Original Paper
Received: February 15, 2013
Accepted: March 18, 2013
Published online: July 13, 2013

Eur Neurol 2013;70:117–123
DOI: 10.1159/000350762

Central Adiposity and Mortality after
First-Ever Acute Ischemic Stroke
Erwin Chiquete a José L. Ruiz-Sandoval c Luis Murillo-Bonilla e
Carolina León-Jiménez g Bertha Ruiz-Madrigal d, f Erika Martínez-López d, f
Sonia Román d, f Arturo Panduro d, f Alma Ramos b Carlos Cantú-Brito a
 

 

 

 

 

 

a

 

 

 

 

Department of Neurology and Psychiatry, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, and
Scientific Area, Sanofi-Aventis, Mexico City, Departments of c Neurology and d Molecular Biology, Hospital Civil de
Guadalajara ‘Fray Antonio Alcalde’, e Departments of Neurology, Facultad de Medicina, Universidad Autónoma de
Guadalajara, and f Department of Molecular Biology, Centro Universitario de Ciencias de la Salud, Universidad de
Guadalajara, Guadalajara, and g Department of Neurology, Hospital Valentín Gomez Farías, Zapopan, Mexico
 

b

 

 

 

 

 

 

Abstract
Background: The waist-to-height ratio (WHtR) may be a better adiposity measure than the body mass index (BMI). We
evaluated the prognostic performance of WHtR in patients
with acute ischemic stroke (AIS). Methods: First, we compared WHtR and BMI as adiposity measures in 712 healthy
adults by tetrapolar bioimpedance analysis. Thereafter,
baseline WHtR was analyzed as predictor of 12-month allcause mortality in 821 Mexican mestizo adults with first-ever
AIS by a Cox proportional hazards model adjusted for baseline predictors. Results: In healthy individuals, WHtR correlated higher than BMI with total fat mass and showed a higher accuracy in identifying a high percentage of body fat (p <
0.01). In AIS patients a U-shaped relationship was observed
between baseline WHtR and mortality (fatality rate 29.1%).
On multivariate analysis, baseline WHtR ≤0.300 or >0.800 independently predicted 12-month all-cause mortality (hazard ratio 1.91, 95% confidence interval 1.04–3.51). BMI was

© 2013 S. Karger AG, Basel
0014–3022/13/0702–0117$38.00/0
E-Mail karger@karger.com
www.karger.com/ene

not associated with mortality, tested either as continuous,
binomial or stratified variable. Conclusion: WHtR is a modifiable risk factor that accurately demonstrates body fat excess.
Extreme WHtR values were associated with increased
12-month all-cause mortality in Mexican mestizo patients
with AIS. No survival advantage was found with high WHtR
as the pragmatic indicator of obesity in this population.
Copyright © 2013 S. Karger AG, Basel

Introduction

Obesity is a well-recognized risk factor for acute ischemic stroke (AIS) [1, 2], however when BMI is tested as
predictor of mortality in people with atherothrombotic
complications such as myocardial infarction, stroke or
heart failure, a high body mass index (BMI) has been associated with a survival advantage (the so-called obesity
paradox) [3–6].
BMI is an index of both lean and fat tissues (i.e. total
body mass) as a function of height squared and therefore
BMI is not the ideal indicator of obesity [7, 8]. Other anthropometric measures, such as the waist-to-height ratio
Dr. Carlos Cantú-Brito
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán
Vasco de Quiroga 15
Tlalpan, Mexico City, CP 14439 (Mexico)
E-Mail carloscantu_brito @ hotmail.com

Downloaded by:
201.141.112.10 - 7/25/2013 1:35:20 PM

Key Words
Adiposity · Body composition · Body fat · Body mass index ·
Obesity paradox · Overweight · Stroke
Methods
We compared WHtR, BMI and other anthropometric measures as references of body adiposity in healthy adults in order to
find the best adiposity index of general adiposity that can be applied in AIS patients to evaluate whether the excessive body fat is
a predictor of 12-month all-cause mortality.
To find the best anthropometric measure of body adiposity, a
total of 712 Mexican mestizo adults without a history of stroke
were invited to receive body composition evaluation at the Department of Molecular Biology in Medicine, Hospital Civil de Guadalajara ‘Fray Antonio Alcalde’, Guadalajara, Mexico. The institutional committee of ethics of the Hospital Civil de Guadalajara
approved this part of the study. Informed consent was required for
all subjects. These individuals underwent evaluation by means of
bioimpedance analysis (BIA) with a computerized multifrequency
tetrapolar 8-point tactile electrode BIA system (Inbody 720; analyzing software: Inbody 3.0; Biospace Co., Ltd, Seoul, Korea). Participating subjects were evaluated in the morning, with cotton underwear without metal or synthetic textiles, in overnight fasting
and having evacuated bladder and rectum. The individuals were
asked to remove their clothes, excepting underwear, and they were
provided with a disposable cotton-made coat for use during BIA.
Hands and soles were cleaned up and impregnated with an electrolyte solution. BMI was calculated as weight (kg) divided by
height (m). WHtR was calculated as waist circumference (WC)
(cm) divided by height (cm), by using the waist measurement of
the narrowest point between the lower costal border and the top of
the iliac crest. Waist-to-hip ratio (WHR) was calculated as WC
(cm) divided by the hip circumference (cm). Body fat and lean
mass content were estimated by using the standard built-in prediction algorithms for adults (Biospace Co., Ltd.).
Among 1,376 participants with AIS or transient ischemic attack (TIA) registered in the PREMIER study [8, 10–12], a total of
821 first-ever AIS patients with complete anthropometric evaluations and 12-month follow-up outcome information were selected
for this part of the study. TIA cases were not included in this analysis. A central institutional review board and the local committee
of ethics of each participating center approved the study. In brief,
consecutive patients with AIS or TIA aged ≥18 years were included. All patients received medical care within 7 days of AIS onset.
Data collection was prospectively performed during 1 year (in six
planned research visits) by using a standardized structured questionnaire outlined in a procedure manual. All participating physicians were instructed on stroke guidelines, classification and management. Stroke subtypes were registered according to Trial of
ORG 10172 in Acute Stroke (TOAST) and Oxfordshire Community Stroke Project (OCSP) classifications. AIS severity was assessed by the National Institutes of Health Stroke Scale (NIHSS) at

118

Eur Neurol 2013;70:117–123
DOI: 10.1159/000350762

baseline, and the modified Rankin scale (mRS) was used to evaluate the functional outcome at hospital discharge, 30 and 90 days,
6, and 12 months after AIS (the six research visits). Weight, height,
and WC were measured at baseline by direct assessment with
scales, stadiometer or flexible metric rulers, with standard procedures for either supine or stand-up positions, as corresponded.
Hip circumference was not measured in this cohort. BMI and
WHtR were calculated as described above. The investigator ascertained every fatality case either directly during hospitalization, or
at each follow-up visit by telephone interview with caregivers. The
exact day of death was recorded. The information of the standardized structured questionnaires was saved on independent electronic files in data capture software developed and revised periodically
by a contract research organization (CRO; Innoval Co.). Members
of the CRO analyzed information on every patient for completeness and plausibility. Missing or implausible variables were referred to the investigator for clarification. Data quality was ascertained by periodic statistical reports and clinical site visits by CRO
monitors.
Parametric continuous variables are expressed as geometric
means and standard deviations (SD), or minimum and maximum. Non-parametric continuous variables are expressed as medians and interquartile range (IQR). Categorical variables are expressed as percentages. To compare quantitative variables distributed between two groups, Student’s t test and Mann-Whitney
U test were performed in distributions of parametric and nonparametric variables, respectively. χ2 statistics were used to compare nominal variables in bivariate analyses. Pearson’s ρ correlation was used to test the continuous association between two
quantitative variables. An r-to-z transformation was performed
to calculate a ‘z’ score that can be applied to assess the significance
of the difference between two correlation coefficients. Different
WHtR, BMI cutoffs, NIHSS cutoffs, and demographic as well as
clinical variables were tested as predictors of 12-month all-cause
mortality in univariate analyses. Variables significantly associated with mortality were selected to integrate a multivariate prediction model. Kaplan-Meyer survival estimates and Cox proportional hazards models at 12-month follow-up were constructed
to find independent baseline risk factors for all-cause mortality
after AIS, testing the WHtR and BMI cutoffs selected in univariate analyses. Multivariate hazard ratios (HR) and their respective
95% confidence intervals (CI) are provided. In healthy subjects,
BMI, WC and WHtR were evaluated by a receiver-operating
characteristic (ROC) curve for discrimination of a percentage of
body fat (%BF) >20 and >30, regarding as superior the index with
the largest area under the curve (AUC) without overlapping 95%
CIs. All p values are two-sided and considered significant when
p < 0.05. SPSS version 17.0 software was used for all statistical
calculations.

Results

WHtR Is Better than BMI as an Index of Adiposity
A total of 712 healthy adults (mean age 38.2, median
38, IQR 28–45 years; 60.5% women) underwent BIA for
body composition assessment. Significant differences
were observed between men and women with respect to
Chiquete  et al.
 

Downloaded by:
201.141.112.10 - 7/25/2013 1:35:20 PM

(WHtR), may denote more precisely the excess of body
adiposity [9]. Growing evidence suggests that WHtR is
stronger than BMI as a risk factor for stroke [2]. In this
study we tested the hypotheses that WHtR is better than
BMI as an index of adiposity in healthy adults and stronger than BMI as predictor of death in Mexican patients
with a first-ever AIS.
Color version available online

80

60

40

AUC (95% CI)
WHtR: 0.908 (0.883–0.932)
BMI: 0.769 (0.729–0.810)
WC: 0.808 (0.771–0.845)
WHR: 0.775 (0.734–0.816)

20

0

0

a

20

40

60

80

100

False positives (%)

True positives (%)

100

80
True positives (%)

100

60

40

AUC (95% CI)
WHtR: 0.961 (0.949–0.973)
BMI: 0.889 (0.866–0.912)
WC: 0.907 (0.886–0.928)
WHR: 0.842 (0.812–0.872)

20

0

0

20

b

40

60

80

100

False positives (%)

Mexican mestizo adults who underwent tetrapolar BIA. b ROC
curve on the discriminatory function of anthropometric indices
for %BF >30.

Table 1. Univariate Pearson’s correlation of several indices of adi-

mean %BF (27.7 vs. 31.8%, respectively; p < 0.001), BMI
(28.5 vs. 25.9, respectively; p < 0.001), WC (93.6 vs. 89.3
cm, respectively; p = 0.001) and WHR (0.880 vs. 0.890,
respectively; p = 0.03), but not with respect to age (38.6
vs. 38.0 years, respectively; p = 0.52) or, more importantly, the WHtR (0.550 vs. 0.560, respectively; p = 0.53). In
healthy adults, WHtR correlated significantly higher
than  BMI with total body fat within each BMI interval
(table 1). Moreover, WHtR showed higher accuracy than
BMI, WC or WHR in identifying both a %BF >20 or >30
(fig. 1a, b).

WHtR Is a Predictor of 12-Month All-Cause Mortality
after a First-Ever AIS
A total of 821 Mexican mestizo patients with AIS (52.6%
women, mean age 67.9, median 70, IQR 57–79 years) were
analyzed for the association of baseline adiposity measures
with 12-month all-cause mortality (table  2). At the
12-month follow-up, a total of 90 (11.0%) patients achieved
a mRS = 0; 191 (23.3%) had a mRS = 1; 109 (13.3%) had a
mRS = 2; 89 (10.8%) had a mRS = 3; 74 (9.0) had a mRS =
4; 29 (3.5%) had a mRS = 5, and 239 (29.1%) patients died.
A U-shaped relationship was observed between WHtR intervals and 12-month all-cause mortality risk (fig. 2a), so
that both low or high baseline WHtR measurements were
associated with an increased 12-month mortality rate. Notably, mean BMI increased as a function of WHtR, but BMI
ranges significantly overlapped across WHtR intervals
(fig. 2a). An inverse relationship was found between the
frequency of hypercholesterolemia and 12-month allcause mortality (table 2), possibly explained by the higher
use of statins among patients with dyslipidemia than
among non-dyslipidemic individuals (9.1 vs. 5.2%, respectively; p = 0.04). Kaplan-Meier estimates showed a significantly lower survival in patients with baseline WHtR
≤0.300 or >0.800 (fig. 2b). Differences in mortality rates
were significant since the first 6 months after AIS (p =
0.03). In a multivariate analysis by the Cox proportional
hazards method adjusted for relevant baseline confounders (table 3), WHtR ≤0.300 or >0.800, age >65 years, to-

Central Adiposity and Mortality in Acute
Stroke

Eur Neurol 2013;70:117–123
DOI: 10.1159/000350762

posity with %BF, according to BMI strata, in 712 healthy adults
who received tetrapolar BIAa
Characteristic BMI <20 BMI 20–25 BMI 25.1–30 BMI >30
(n = 48) (n = 285)
(n = 197)
(n = 182)
WHtR
BMI
WC
WHR

0.773b
0.401b
0.614b
0.597b

0.702b
0.237b
0.396b
0.355b

0.864b
0.460b
0.557b
0.530b

–0.715b
–0.666b
–0.423b
–0.026

a p < 0.05 for comparison of Pearson’s correlation between BMI

and total body fat with that of WHtR and total body fat.
b p < 0.001 for significance of univariate Pearson’s correlation.

119

Downloaded by:
201.141.112.10 - 7/25/2013 1:35:20 PM

Fig. 1. Accuracy of anthropometric measures in identifying excessive adiposity in healthy adults. a ROC curve on the discriminatory function of anthropometric indices for %BF >20 in 712 healthy
Table 2. Main characteristics of patients with a first-ever acute cerebral infarction (n = 821) and their association with 12-month allcause mortality

Variable

12-Month all-cause mortality
absent (n = 582)

Median age, years
Male
NIHSS at hospital admission, median
Major vascular risk factors
Hypertension
Diabetes mellitus
Hypercholesterolemia
Atrial fibrillation
Coronary artery disease
Heart failure
Past or current smoking
Ischemic stroke syndromes
Total anterior circulation cerebral infarction
Partial anterior circulation cerebral infarction
Lacunar cerebral infarction
Posterior circulation cerebral infarction
Ischemic stroke mechanisms
Large-artery atherothrombosis
Lacunar
Cardioembolism
Mixed mechanism
Other determined mechanisms
Undetermined mechanism
Baseline anthropometric measures
Weight, kg
Height, m
WC, cm
WHtR
Body mass index
>25
>27
>30
>35

68.0 [56.0–77.0]
282 (48.5)
8.0 [5.0–13.0]

p value

present (n = 239)
77.00 [65.0–85.0]
107 (44.8)
19.0 [14.0–26.5]

373 (64.1)
199 (34.2)
136 (23.4)
44 (7.6)
70 (12.0)
40 (6.9)
212 (36.4)

157 (65.7)
84 (35.1)
29 (12.1)
46 (19.2)
36 (15.1)
38 (15.9)
93 (38.9)

54 (9.3)
238 (40.9)
190 (32.6)
100 (17.2)

119 (49.8)
72 (30.1)
13 (5.4)
35 (14.6)

56 (9.6)
140 (24.1)
91 (15.6)
33 (5.7)
35 (6.0)
227 (39.0)

9 (3.8)
12 (5.0)
65 (27.2)
12 (5.0)
9 (3.8)
132 (55.2)

71.8±4.6
1.62±0.09
93.3±15.4
0.577±0.096
27.35±4.66
406 (69.8)
290 (49.8)
138 (23.7)
30 (5.2)

70.4±15.3
1.61±0.09
93.7±17.4
0.584±0.105
27.19±5.20
153 (64.0)
120 (50.2)
62 (25.9)
15 (6.3)

<0.001
<0.34
<0.001
<0.66
<0.79
<0.001
<0.001
<0.24
<0.001
<0.50
<0.001

<0.001

<0.19
<0.10
<0.75
<0.41
<0.67
<0.11
<0.92
<0.50
<0.52

Values are mean ± SD, n (%) or IQR in brackets.

Discussion

When compared with BMI these results demonstrate
that WHtR is a better measure of adiposity and a stronger
predictor of 12-month all-cause mortality in Mexican
120

Eur Neurol 2013;70:117–123
DOI: 10.1159/000350762

mestizo patients with AIS. We found a U-shaped relationship between WHtR and mortality, and therefore did
not observe any protective effect of a high BMI or high
WHtR in this first-ever AIS cohort.
WHtR has been traditionally considered an anthropometric measure of central adiposity adjusted for a given
height [7, 9]. Here we show that WHtR can accurately
indicate general adiposity as well. Central adiposity has
been found to be associated with an adverse metabolic
profile that traduce into a high cardiovascular risk [9]. If
WC parallels with increments of visceral fat tissue when
weight gain occurs at the expense of positive energy balChiquete  et al.
 

Downloaded by:
201.141.112.10 - 7/25/2013 1:35:20 PM

tal anterior circulation cerebral infarction syndrome, and
NIHSS were significant predictors of 12-month all-cause
mortality (table  3). BMI was not significantly associated
with 12-month mortality, tested either as a continuous, binomial or stratified variable (table 3).
2

20

0

0

Deaths, n
Number at risk

a

BMI
Mean
SD
Range

100

80

WHtR 0.301–0.800

60

40

WHtR

20

Fig. 2. All-cause mortality after a first-ever
AIS. a One-year all-cause mortality ac-

cording to baseline WHtR: in circles, relative frequency; in triangles, age- and sexadjusted HRs. The corresponding BMI for
every WHtR interval is also shown. b Kaplan-Meier estimates according to baseline
WHtR ≤0.300 or >0.800. Rhombuses indicate censored cases.

0

Number at risk
WHtR 0.301–0.800
b WHtR

0

802
19

100
200
300
Days after first-ever AIS
614
11

593
10

400

570
8

As reflected by WHtR, in the present study both a reduced and an excessive central adiposity increase the
probability of death after a first-ever cerebral infarction.
Indeed, on the one hand it is possible that certain energy
stores are necessary to cope with metabolic demands that
follow AIS [8, 13, 14], and on the other hand, an excessive
visceral fat could be associated with an adverse risk profile. When analyzing a high BMI as a predictor of mortality in subjects who have survived an atherothrombotic

Central Adiposity and Mortality in Acute
Stroke

Eur Neurol 2013;70:117–123
DOI: 10.1159/000350762

121

Downloaded by:
201.141.112.10 - 7/25/2013 1:35:20 PM

ance, then WHtR may denote more accurately the most
important body mass in terms of chronic risks. Both
obese and muscled persons can have the same BMI if
weight (with different proportions of lean and fat masses)
and height are the same, but with radically different risks.
On the other hand, WC does not increase significantly in
muscled individuals; hence, the adjustment of WC for
height provides the opportunity of correcting central adiposity for variations of height.
Table 3. Multivariate analysis on baseline factors associated with
12-month all-cause mortality in patients with a first-ever acute cerebral infarction (n = 821): a Cox proportional hazards modela

Predictor

HR (95% CI)

p value

TACI
NIHSSb
WHtR ≤0.300 or >0.800
Agec

2.435 (1.759−3.371)
2.182 (1.751−2.720)
1.911 (1.040−3.514)
1.018 (1.008−1.027)

<0.001
<0.001
<0.037
<0.001

a

  Adjusted for atrial fibrillation, hypercholesterolemia, statin
use, heart failure, stroke mechanisms, stroke syndromes, BMI
(tested as a continuous, stratified or binomial variable with different cutoffs), WC and total body weight.
b
 NIHSS <9, 9–18 and >18 points.
c
 Age per 1-year increment.

complication (i.e. stroke, myocardial infarction, heart
failure, and other complications), it can be erroneously
concluded that obesity provides a survival advantage, a
concept that may be misinterpreted by the general population, with potential negative consequences for public
health.
Our findings are in conflict with the obesity paradox
concept. In a previous analysis of the PREMIER cohort,
we originally found that a high BMI was apparently associated with a good functional outcome in stroke survivors exclusively [8], confirming the obesity paradox in
the context of functional recovery. However, when WHtR
was analyzed as a measure of adiposity excess (i.e. obesity), no functional advantage was found with high WHtR
or high BMI in adjusted multivariate analyses [8]. It is
possible that the elimination of patients with a previous
stroke can reduce the bias of survival selection for the
obese individuals, then reducing the apparent advantage
with high BMI values. In other words, it remains unquestionable that a high BMI is strongly associated with increased mortality and cardiovascular risks [15–17], but

when studying persons who already have a cardiovascular
event, and the onset of such an event is the new ‘zero
point’ for mortality analysis, the inclusion of obese patients who had survived several cardiovascular events
may bias towards the selection of strong body constitutions that may be more ‘resistant’ to the metabolic challenges after atherothrombotic events in the long run. So
far, no indisputable explanation to the obesity paradox
concept has been put forward [18].
The main limitation of our study is the lack of direct
body composition analysis in the cohort with AIS, which
would allow for estimation of the exact predictive value
of adiposity in diseased persons. Another limitation is the
relatively small sample size that might hamper robust
analyses. At the population level different WHtR cutoffs
may apply in terms of long-term cardiometabolic risks, if
we consider that the present study was only about patients with arterial disease at baseline. Given the body
composition characteristics of the Mexican mestizo population, our findings should be tested in different bioethnic groups and other forms of cerebrovascular and cardiometabolic diseases.
In conclusion, extreme WHtR values are modestly, but
significantly associated with an increased all-cause mortality risk in Mexican mestizos, in the late part of the evolution after a first-ever AIS. These findings should be retested in different scenarios.
Disclosure Statement
This study received unrestricted funds from Sanofi-Aventis for
the registering of patients with stroke. The company did not participate, either directly or indirectly in study design, selection of
patients, data analysis, manuscript draft or the decision to summit
for publication.
Mrs. A. Ramos is employed by Sanofi-Aventis, Mexico, in the
Clinical Research Area, and Dr. C. Cantú-Brito served in the Scientific Advisory Board of the PREMIER Registry. None of the other authors have any conflicts of interest to disclose.

References

122

risk of stroke: the MOnica Risk, Genetics, Archiving and Monograph (MORGAM) study.
Stroke 2011;42:2872–2877.
3 Gruberg L, Weissman NJ, Waksman R, Fuchs
S, Deible R, Pinnow EE, Ahmed LM, Kent
KM, Pichard AD, Suddath WO, Satler LF,
Lindsay J Jr: The impact of obesity on the
short-term and long-term outcomes after percutaneous coronary intervention: the obesity
paradox? J Am Coll Cardiol 2002;39:578–584.

Eur Neurol 2013;70:117–123
DOI: 10.1159/000350762

4 Curtis JP, Selter JG, Wang Y, Rathore SS, Jovin IS, Jadbabaie F, Kosiborod M, Portnay EL,
Sokol SI, Bader F, Krumholz HM: The obesity
paradox: body mass index and outcomes in
patients with heart failure. Arch Intern Med
2005;165:55–61.
5 Kim BJ, Lee SH, Ryu WS, Kim CK, Lee J, Yoon
BW: Paradoxical longevity in obese patients
with intracerebral hemorrhage. Neurology
2011;76:567–573.

Chiquete  et al.
 

Downloaded by:
201.141.112.10 - 7/25/2013 1:35:20 PM

1 Oki I, Nakamura Y, Okamura T, Okayama A,
Hayakawa T, Kita Y, Ueshima H: Nippon Data80
Research Group: Body mass index and risk of
stroke mortality among a random sample of
Japanese adults: 19-year follow-up of NIPPON
DATA80. Cerebrovasc Dis 2006;22:409–415.
2 Bodenant M, Kuulasmaa K, Wagner A, Kee F,
Palmieri L, Ferrario MM, Montaye M,
Amouyel P, Dallongeville J: MORGAM Project: measures of abdominal adiposity and the
Central Adiposity and Mortality in Acute
Stroke

10 Cantú-Brito C, Ruiz-Sandoval JL, MurilloBonilla LM, Chiquete E, León-Jiménez C,
Arauz A, Villarreal-Careaga J, Barinagarrementeria F, Ramos-Moreno A; PREMIER Investigators: The first Mexican multicenter
register on ischaemic stroke (the PREMIER
study): demographics, risk factors and outcome. Int J Stroke 2011;6:93–94.
11 Cantú-Brito C, Ruiz-Sandoval JL, MurilloBonilla LM, Chiquete E, León-Jiménez C,
Arauz A, Villarreal-Careaga J, Barinagarrementeria F, Ramos-Moreno A; PREMIER Investigators: Acute care and one-year outcome
of Mexican patients with first-ever acute ischemic stroke: the PREMIER study. Rev Neurol
2010;51:641–649.
12 Chiquete E, Ruiz-Sandoval JL, Murillo-Bonilla LM, Arauz-Góngora A, Ochoa-Guzmán A,
Villarreal-Careaga J, León-Jiménez C, Barinagarrementeria F, Ramos-Moreno A,
Cantú-Brito C: Serum uric acid and outcome
after acute ischemic stroke: PREMIER study.
Cerebrovasc Dis 2013;35:168–174.

13 Koton S, Molshatzki N, Bornstein NM, Tanne
D: Low cholesterol, statins and outcomes in
patients with first-ever acute ischemic stroke.
Cerebrovasc Dis 2012;34:213–220.
14 Ryu WS, Lee SH, Kim CK, Kim BJ, Yoon BW:
Body mass index, initial neurological severity
and long-term mortality in ischemic stroke.
Cerebrovasc Dis 2011;32:170–176.
15 Calle EE, Thun MJ, Petrelli JM, Rodriguez C,
Heath CW Jr: Body mass index and mortality
in a prospective cohort of US adults. N Engl J
Med 1999;341:1097–1105.
16 Jee SH, Sull JW, Park J, Lee SY, Ohrr H, Guallar E, Samet JM: Body mass index and mortality in Korean men and women. N Engl J Med
2006;355:779–787.
17 Pischon T, Boeing H, Hoffmann K, Bergmann M, Schulze MB, Overvad K: General
and abdominal adiposity and risk of death in
Europe. N Engl J Med 2008; 359: 2105–2120.
Erratum in: N Engl J Med 2010;362:2433.
18 Chrysant SG, Chrysant GS: New insights into
the true nature of the obesity paradox and the
lower cardiovascular risk. J Am Soc Hypertens 2013;7:85–94.

Eur Neurol 2013;70:117–123
DOI: 10.1159/000350762

123

Downloaded by:
201.141.112.10 - 7/25/2013 1:35:20 PM

6 Vemmos K, Ntaios G, Spengos K, Savvari P,
Vemmou A, Pappa T, Manios E, Georgiopoulos G, Alevizaki M: Association between obesity and mortality after acute first-ever stroke:
the obesity-stroke paradox. Stroke 2011; 42:
30–36.
7 Lee K, Song YM, Sung J: Which obesity indicators are better predictors of metabolic risk?
Healthy twin study. Obesity (Silver Spring)
2008;16:834–840.
8 Chiquete E, Cantú-Brito C, Villarreal-Careaga
J, Murillo-Bonilla LM, Rangel-Guerra R, LeónJiménez C, Ochoa-Guzmán A, Ramos-Moreno A, Arauz A, Barinagarrementeria F, Panduro A, Ruiz-Sandoval JL: Obesity paradox
and functional recovery in first-ever acute
ischemic stroke survivors: the PREMIER study
(in Spanish). Rev Neurol 2010;51:705–713.
9 Ashwell M, Gunn P, Gibson S: Waist-toheight ratio is a better screening tool than
waist circumference and BMI for adult cardiometabolic risk factors: systematic review
and meta-analysis. Obes Rev 2012; 13: 275–
286.

Más contenido relacionado

La actualidad más candente

Total and Cause-Specific Mortality of U.S. Nurses Working Rotating Night Shifts
Total and Cause-Specific Mortality of U.S. Nurses Working Rotating Night ShiftsTotal and Cause-Specific Mortality of U.S. Nurses Working Rotating Night Shifts
Total and Cause-Specific Mortality of U.S. Nurses Working Rotating Night ShiftsEmergency Live
 
Meta analisis of statin
Meta analisis of statinMeta analisis of statin
Meta analisis of statinEmy Oktaviani
 
Manual of Geriatric Anesthesia
Manual of Geriatric AnesthesiaManual of Geriatric Anesthesia
Manual of Geriatric AnesthesiaSpringer
 
Perioperative delirium
Perioperative deliriumPerioperative delirium
Perioperative deliriumCamilla Wong
 
Improved diagnosis and prognosis using Decisions Informed by Combining Entiti...
Improved diagnosis and prognosis using Decisions Informed by Combining Entiti...Improved diagnosis and prognosis using Decisions Informed by Combining Entiti...
Improved diagnosis and prognosis using Decisions Informed by Combining Entiti...Cardiovascular Diagnosis and Therapy (CDT)
 
Management of pediatric blunt renal trauma a systematic review
Management of pediatric blunt renal trauma  a systematic reviewManagement of pediatric blunt renal trauma  a systematic review
Management of pediatric blunt renal trauma a systematic reviewskrentz
 
Substance abuse & sirs.published article.6.17.11.docx
Substance abuse & sirs.published article.6.17.11.docxSubstance abuse & sirs.published article.6.17.11.docx
Substance abuse & sirs.published article.6.17.11.docxElizabeth "Beth" NeSmith
 
Statin Use Cancer Related Mortality M Wilmath Nov2012 Whh Adult Med
Statin Use Cancer Related Mortality M Wilmath Nov2012 Whh Adult MedStatin Use Cancer Related Mortality M Wilmath Nov2012 Whh Adult Med
Statin Use Cancer Related Mortality M Wilmath Nov2012 Whh Adult MedMario Wilmath
 
Cardiac rehab 2010 study
Cardiac rehab 2010 studyCardiac rehab 2010 study
Cardiac rehab 2010 studymb1028
 
HEALTH ECONOMICS
HEALTH ECONOMICSHEALTH ECONOMICS
HEALTH ECONOMICSImran Javed
 
Zura '16-JAMA Surg-Epidemiology
Zura '16-JAMA Surg-EpidemiologyZura '16-JAMA Surg-Epidemiology
Zura '16-JAMA Surg-EpidemiologyGrant Steen
 

La actualidad más candente (16)

Total and Cause-Specific Mortality of U.S. Nurses Working Rotating Night Shifts
Total and Cause-Specific Mortality of U.S. Nurses Working Rotating Night ShiftsTotal and Cause-Specific Mortality of U.S. Nurses Working Rotating Night Shifts
Total and Cause-Specific Mortality of U.S. Nurses Working Rotating Night Shifts
 
Meta analisis of statin
Meta analisis of statinMeta analisis of statin
Meta analisis of statin
 
Manual of Geriatric Anesthesia
Manual of Geriatric AnesthesiaManual of Geriatric Anesthesia
Manual of Geriatric Anesthesia
 
Perioperative delirium
Perioperative deliriumPerioperative delirium
Perioperative delirium
 
Improved diagnosis and prognosis using Decisions Informed by Combining Entiti...
Improved diagnosis and prognosis using Decisions Informed by Combining Entiti...Improved diagnosis and prognosis using Decisions Informed by Combining Entiti...
Improved diagnosis and prognosis using Decisions Informed by Combining Entiti...
 
Management of pediatric blunt renal trauma a systematic review
Management of pediatric blunt renal trauma  a systematic reviewManagement of pediatric blunt renal trauma  a systematic review
Management of pediatric blunt renal trauma a systematic review
 
Substance abuse & sirs.published article.6.17.11.docx
Substance abuse & sirs.published article.6.17.11.docxSubstance abuse & sirs.published article.6.17.11.docx
Substance abuse & sirs.published article.6.17.11.docx
 
Statin Use Cancer Related Mortality M Wilmath Nov2012 Whh Adult Med
Statin Use Cancer Related Mortality M Wilmath Nov2012 Whh Adult MedStatin Use Cancer Related Mortality M Wilmath Nov2012 Whh Adult Med
Statin Use Cancer Related Mortality M Wilmath Nov2012 Whh Adult Med
 
Deep learning-approach
Deep learning-approachDeep learning-approach
Deep learning-approach
 
Cardiac rehab 2010 study
Cardiac rehab 2010 studyCardiac rehab 2010 study
Cardiac rehab 2010 study
 
Goodman et al-2017-arthritis_&amp;_rheumatology
Goodman et al-2017-arthritis_&amp;_rheumatologyGoodman et al-2017-arthritis_&amp;_rheumatology
Goodman et al-2017-arthritis_&amp;_rheumatology
 
HEALTH ECONOMICS
HEALTH ECONOMICSHEALTH ECONOMICS
HEALTH ECONOMICS
 
Jurnal 2 wawan
Jurnal 2 wawanJurnal 2 wawan
Jurnal 2 wawan
 
Challenge of Practice Variations
Challenge of Practice VariationsChallenge of Practice Variations
Challenge of Practice Variations
 
Zura '16-JAMA Surg-Epidemiology
Zura '16-JAMA Surg-EpidemiologyZura '16-JAMA Surg-Epidemiology
Zura '16-JAMA Surg-Epidemiology
 
Wennberg at Group Health 3-25-11
Wennberg at Group Health 3-25-11Wennberg at Group Health 3-25-11
Wennberg at Group Health 3-25-11
 

Destacado

America Eco Challenge and Social Competition
America Eco Challenge and Social Competition America Eco Challenge and Social Competition
America Eco Challenge and Social Competition Andre Botelho Bastos
 
Снегоуборщик электрический - электролопата Stiga ST 1131 E
Снегоуборщик электрический - электролопата Stiga ST 1131 EСнегоуборщик электрический - электролопата Stiga ST 1131 E
Снегоуборщик электрический - электролопата Stiga ST 1131 EAl Maks
 
Collaborative work leidy-poveda_&_eduar_giraldo[1] finish
Collaborative work leidy-poveda_&_eduar_giraldo[1] finishCollaborative work leidy-poveda_&_eduar_giraldo[1] finish
Collaborative work leidy-poveda_&_eduar_giraldo[1] finishEduar Ferney
 
Energy conciliation presentation
Energy conciliation presentationEnergy conciliation presentation
Energy conciliation presentationconsumerenergy
 
Международная стажировка в республику Корея - 2013 год
Международная стажировка в республику Корея - 2013 годМеждународная стажировка в республику Корея - 2013 год
Международная стажировка в республику Корея - 2013 годAntonina Navros
 
Candidate c film_industry
Candidate c film_industryCandidate c film_industry
Candidate c film_industrynctcmedia12
 
DB Security Oracle 11g-Application Context, Dynamic Views & Aduits
DB Security Oracle 11g-Application Context, Dynamic Views & AduitsDB Security Oracle 11g-Application Context, Dynamic Views & Aduits
DB Security Oracle 11g-Application Context, Dynamic Views & AduitsSunny U Okoro
 
Lyserødlørdag 2012
Lyserødlørdag 2012Lyserødlørdag 2012
Lyserødlørdag 2012Merethe Kepp
 
Open electricity market Latvia
Open electricity market LatviaOpen electricity market Latvia
Open electricity market Latviaconsumerenergy
 
BI Apps Reports 4 Cognos BI and Crystal Reports
BI Apps Reports 4  Cognos BI and Crystal ReportsBI Apps Reports 4  Cognos BI and Crystal Reports
BI Apps Reports 4 Cognos BI and Crystal ReportsSunny U Okoro
 

Destacado (20)

America Eco Challenge and Social Competition
America Eco Challenge and Social Competition America Eco Challenge and Social Competition
America Eco Challenge and Social Competition
 
Daftarhadir&nilai statistik
Daftarhadir&nilai statistikDaftarhadir&nilai statistik
Daftarhadir&nilai statistik
 
Снегоуборщик электрический - электролопата Stiga ST 1131 E
Снегоуборщик электрический - электролопата Stiga ST 1131 EСнегоуборщик электрический - электролопата Stiga ST 1131 E
Снегоуборщик электрический - электролопата Stiga ST 1131 E
 
Collaborative work leidy-poveda_&_eduar_giraldo[1] finish
Collaborative work leidy-poveda_&_eduar_giraldo[1] finishCollaborative work leidy-poveda_&_eduar_giraldo[1] finish
Collaborative work leidy-poveda_&_eduar_giraldo[1] finish
 
Energy conciliation presentation
Energy conciliation presentationEnergy conciliation presentation
Energy conciliation presentation
 
Soalan s po t psk 3103
Soalan s po t psk 3103Soalan s po t psk 3103
Soalan s po t psk 3103
 
An approach for OSGi and DPWS interoperability: Bridging enterprise applicati...
An approach for OSGi and DPWS interoperability: Bridging enterprise applicati...An approach for OSGi and DPWS interoperability: Bridging enterprise applicati...
An approach for OSGi and DPWS interoperability: Bridging enterprise applicati...
 
Heyat terzi
Heyat terziHeyat terzi
Heyat terzi
 
Международная стажировка в республику Корея - 2013 год
Международная стажировка в республику Корея - 2013 годМеждународная стажировка в республику Корея - 2013 год
Международная стажировка в республику Корея - 2013 год
 
Candidate c film_industry
Candidate c film_industryCandidate c film_industry
Candidate c film_industry
 
BCG Matrix
BCG MatrixBCG Matrix
BCG Matrix
 
DB Security Oracle 11g-Application Context, Dynamic Views & Aduits
DB Security Oracle 11g-Application Context, Dynamic Views & AduitsDB Security Oracle 11g-Application Context, Dynamic Views & Aduits
DB Security Oracle 11g-Application Context, Dynamic Views & Aduits
 
Risk Assessment
Risk AssessmentRisk Assessment
Risk Assessment
 
Incubix
IncubixIncubix
Incubix
 
Flyer
Flyer Flyer
Flyer
 
5 penyebaran data
5 penyebaran data5 penyebaran data
5 penyebaran data
 
Lean canvas idoor
Lean canvas   idoorLean canvas   idoor
Lean canvas idoor
 
Lyserødlørdag 2012
Lyserødlørdag 2012Lyserødlørdag 2012
Lyserødlørdag 2012
 
Open electricity market Latvia
Open electricity market LatviaOpen electricity market Latvia
Open electricity market Latvia
 
BI Apps Reports 4 Cognos BI and Crystal Reports
BI Apps Reports 4  Cognos BI and Crystal ReportsBI Apps Reports 4  Cognos BI and Crystal Reports
BI Apps Reports 4 Cognos BI and Crystal Reports
 

Similar a Central Adiposity and Mortality after First-Ever Acute Ischemic Stroke

Serum Uric Acid and Outcome after Acute Ischemic Stroke: PREMIER Study
Serum Uric Acid and Outcome after Acute Ischemic Stroke: PREMIER StudySerum Uric Acid and Outcome after Acute Ischemic Stroke: PREMIER Study
Serum Uric Acid and Outcome after Acute Ischemic Stroke: PREMIER StudyErwin Chiquete, MD, PhD
 
Insurance | Stratifying risk using wearable data | MunichRe
Insurance | Stratifying risk using wearable data | MunichReInsurance | Stratifying risk using wearable data | MunichRe
Insurance | Stratifying risk using wearable data | MunichReGalen Growth
 
Red blood cell and at this effect of diabetes mil lute
Red blood cell and at this effect of diabetes mil lute Red blood cell and at this effect of diabetes mil lute
Red blood cell and at this effect of diabetes mil lute ScSyed
 
MPH Thesis Tesfaye Kasaye
MPH Thesis Tesfaye KasayeMPH Thesis Tesfaye Kasaye
MPH Thesis Tesfaye KasayeTesfaye Abrhame
 
Pathophysiology Of Heart Failure
Pathophysiology Of Heart FailurePathophysiology Of Heart Failure
Pathophysiology Of Heart FailureStephanie King
 
Diabetes In Diabetes
Diabetes In DiabetesDiabetes In Diabetes
Diabetes In DiabetesKristin Reyes
 
Gout treatment-guidelines-2021
Gout treatment-guidelines-2021Gout treatment-guidelines-2021
Gout treatment-guidelines-2021DrTreatment1
 
predictors of mortality in mechanically ventilated patients using APACHE II a...
predictors of mortality in mechanically ventilated patients using APACHE II a...predictors of mortality in mechanically ventilated patients using APACHE II a...
predictors of mortality in mechanically ventilated patients using APACHE II a...Raj Mehta
 
08 exemplo de revisão sistemática
08   exemplo de revisão sistemática08   exemplo de revisão sistemática
08 exemplo de revisão sistemáticagisa_legal
 
Postgrad med j 2015-pflug-77-82
Postgrad med j 2015-pflug-77-82Postgrad med j 2015-pflug-77-82
Postgrad med j 2015-pflug-77-82jhon huillca
 
Purple and white modern advertising presentation
Purple and white modern advertising presentationPurple and white modern advertising presentation
Purple and white modern advertising presentationAnjuPremy
 
CABGPostOpPneumoniaPaper
CABGPostOpPneumoniaPaperCABGPostOpPneumoniaPaper
CABGPostOpPneumoniaPaperRaymond Strobel
 
Association of Physical Activity with Lipid Profile in [Recovered].pptx
Association of Physical Activity with Lipid Profile in [Recovered].pptxAssociation of Physical Activity with Lipid Profile in [Recovered].pptx
Association of Physical Activity with Lipid Profile in [Recovered].pptxVikaspal557083
 
Jan 2016 iep
Jan 2016 iepJan 2016 iep
Jan 2016 iepbahlinnm
 
Precision of Repeated Peripheral and Visceral Adipose Tissue Quantification u...
Precision of Repeated Peripheral and Visceral Adipose Tissue Quantification u...Precision of Repeated Peripheral and Visceral Adipose Tissue Quantification u...
Precision of Repeated Peripheral and Visceral Adipose Tissue Quantification u...asclepiuspdfs
 

Similar a Central Adiposity and Mortality after First-Ever Acute Ischemic Stroke (20)

Serum Uric Acid and Outcome after Acute Ischemic Stroke: PREMIER Study
Serum Uric Acid and Outcome after Acute Ischemic Stroke: PREMIER StudySerum Uric Acid and Outcome after Acute Ischemic Stroke: PREMIER Study
Serum Uric Acid and Outcome after Acute Ischemic Stroke: PREMIER Study
 
Insurance | Stratifying risk using wearable data | MunichRe
Insurance | Stratifying risk using wearable data | MunichReInsurance | Stratifying risk using wearable data | MunichRe
Insurance | Stratifying risk using wearable data | MunichRe
 
Red blood cell and at this effect of diabetes mil lute
Red blood cell and at this effect of diabetes mil lute Red blood cell and at this effect of diabetes mil lute
Red blood cell and at this effect of diabetes mil lute
 
MPH Thesis Tesfaye Kasaye
MPH Thesis Tesfaye KasayeMPH Thesis Tesfaye Kasaye
MPH Thesis Tesfaye Kasaye
 
Pathophysiology Of Heart Failure
Pathophysiology Of Heart FailurePathophysiology Of Heart Failure
Pathophysiology Of Heart Failure
 
Diabetes In Diabetes
Diabetes In DiabetesDiabetes In Diabetes
Diabetes In Diabetes
 
2013 04 aims65 vs blatchford
2013 04 aims65 vs blatchford2013 04 aims65 vs blatchford
2013 04 aims65 vs blatchford
 
Curb 65 thorax-2003-lim-377-82
Curb 65 thorax-2003-lim-377-82Curb 65 thorax-2003-lim-377-82
Curb 65 thorax-2003-lim-377-82
 
Gout treatment-guidelines-2021
Gout treatment-guidelines-2021Gout treatment-guidelines-2021
Gout treatment-guidelines-2021
 
Waist circumference
Waist circumferenceWaist circumference
Waist circumference
 
predictors of mortality in mechanically ventilated patients using APACHE II a...
predictors of mortality in mechanically ventilated patients using APACHE II a...predictors of mortality in mechanically ventilated patients using APACHE II a...
predictors of mortality in mechanically ventilated patients using APACHE II a...
 
08 exemplo de revisão sistemática
08   exemplo de revisão sistemática08   exemplo de revisão sistemática
08 exemplo de revisão sistemática
 
Postgrad med j 2015-pflug-77-82
Postgrad med j 2015-pflug-77-82Postgrad med j 2015-pflug-77-82
Postgrad med j 2015-pflug-77-82
 
Purple and white modern advertising presentation
Purple and white modern advertising presentationPurple and white modern advertising presentation
Purple and white modern advertising presentation
 
D-dimer.full
D-dimer.fullD-dimer.full
D-dimer.full
 
CABGPostOpPneumoniaPaper
CABGPostOpPneumoniaPaperCABGPostOpPneumoniaPaper
CABGPostOpPneumoniaPaper
 
Association of Physical Activity with Lipid Profile in [Recovered].pptx
Association of Physical Activity with Lipid Profile in [Recovered].pptxAssociation of Physical Activity with Lipid Profile in [Recovered].pptx
Association of Physical Activity with Lipid Profile in [Recovered].pptx
 
Jan 2016 iep
Jan 2016 iepJan 2016 iep
Jan 2016 iep
 
432.full
432.full432.full
432.full
 
Precision of Repeated Peripheral and Visceral Adipose Tissue Quantification u...
Precision of Repeated Peripheral and Visceral Adipose Tissue Quantification u...Precision of Repeated Peripheral and Visceral Adipose Tissue Quantification u...
Precision of Repeated Peripheral and Visceral Adipose Tissue Quantification u...
 

Más de Erwin Chiquete, MD, PhD

Mortalidad asociada al diagnóstico de síndrome de Guillain-Barré en adultos i...
Mortalidad asociada al diagnóstico de síndrome de Guillain-Barré en adultos i...Mortalidad asociada al diagnóstico de síndrome de Guillain-Barré en adultos i...
Mortalidad asociada al diagnóstico de síndrome de Guillain-Barré en adultos i...Erwin Chiquete, MD, PhD
 
Seroepidemiology of Toxoplasma gondii infection in drivers involved in road t...
Seroepidemiology of Toxoplasma gondii infection in drivers involved in road t...Seroepidemiology of Toxoplasma gondii infection in drivers involved in road t...
Seroepidemiology of Toxoplasma gondii infection in drivers involved in road t...Erwin Chiquete, MD, PhD
 
Tiempo de llegada hospitalaria y pronóstico funcional después deun infarto ce...
Tiempo de llegada hospitalaria y pronóstico funcional después deun infarto ce...Tiempo de llegada hospitalaria y pronóstico funcional después deun infarto ce...
Tiempo de llegada hospitalaria y pronóstico funcional después deun infarto ce...Erwin Chiquete, MD, PhD
 
Comportamiento del barorreflejo en pacientes con síncope vasovagal durante el...
Comportamiento del barorreflejo en pacientes con síncope vasovagal durante el...Comportamiento del barorreflejo en pacientes con síncope vasovagal durante el...
Comportamiento del barorreflejo en pacientes con síncope vasovagal durante el...Erwin Chiquete, MD, PhD
 
Delírium en adultos que reciben cuidados paliativos: revisión de laliteratura...
Delírium en adultos que reciben cuidados paliativos: revisión de laliteratura...Delírium en adultos que reciben cuidados paliativos: revisión de laliteratura...
Delírium en adultos que reciben cuidados paliativos: revisión de laliteratura...Erwin Chiquete, MD, PhD
 
Massive Non-Encephalitic Neurocysticercosis
Massive Non-Encephalitic NeurocysticercosisMassive Non-Encephalitic Neurocysticercosis
Massive Non-Encephalitic NeurocysticercosisErwin Chiquete, MD, PhD
 
Cost of care according to disease-modifying therapy in Mexicans with relapsin...
Cost of care according to disease-modifying therapy in Mexicans with relapsin...Cost of care according to disease-modifying therapy in Mexicans with relapsin...
Cost of care according to disease-modifying therapy in Mexicans with relapsin...Erwin Chiquete, MD, PhD
 
Blood pressure at hospital admission and outcome after primary intracerebral ...
Blood pressure at hospital admission and outcome after primary intracerebral ...Blood pressure at hospital admission and outcome after primary intracerebral ...
Blood pressure at hospital admission and outcome after primary intracerebral ...Erwin Chiquete, MD, PhD
 
Hepatitis C virus infection and type 2 diabetes mellitus in Mexican patients.
Hepatitis C virus infection and type 2 diabetes mellitus in Mexican patients. Hepatitis C virus infection and type 2 diabetes mellitus in Mexican patients.
Hepatitis C virus infection and type 2 diabetes mellitus in Mexican patients. Erwin Chiquete, MD, PhD
 
Atherothrombotic Disease, Traditional Risk Factors, and 4-Year Mortality in a...
Atherothrombotic Disease, Traditional Risk Factors, and 4-Year Mortality in a...Atherothrombotic Disease, Traditional Risk Factors, and 4-Year Mortality in a...
Atherothrombotic Disease, Traditional Risk Factors, and 4-Year Mortality in a...Erwin Chiquete, MD, PhD
 
Atypical forms of the osmotic demyelination syndrome
Atypical forms of the osmotic demyelination syndromeAtypical forms of the osmotic demyelination syndrome
Atypical forms of the osmotic demyelination syndromeErwin Chiquete, MD, PhD
 
Spontaneous intracerebral hemorrhage in Mexico: results from a Multicenter Na...
Spontaneous intracerebral hemorrhage in Mexico: results from a Multicenter Na...Spontaneous intracerebral hemorrhage in Mexico: results from a Multicenter Na...
Spontaneous intracerebral hemorrhage in Mexico: results from a Multicenter Na...Erwin Chiquete, MD, PhD
 
An Expandable Prosthesis with Dual Cage-and-Plate Function in a Single Device...
An Expandable Prosthesis with Dual Cage-and-Plate Function in a Single Device...An Expandable Prosthesis with Dual Cage-and-Plate Function in a Single Device...
An Expandable Prosthesis with Dual Cage-and-Plate Function in a Single Device...Erwin Chiquete, MD, PhD
 
Expression profile of BRCA1 and BRCA2 genes in premenopausal Mexican women wi...
Expression profile of BRCA1 and BRCA2 genes in premenopausal Mexican women wi...Expression profile of BRCA1 and BRCA2 genes in premenopausal Mexican women wi...
Expression profile of BRCA1 and BRCA2 genes in premenopausal Mexican women wi...Erwin Chiquete, MD, PhD
 
Demencia asociada a intoxicación por paradiclorobenceno
Demencia asociada a intoxicación por paradiclorobencenoDemencia asociada a intoxicación por paradiclorobenceno
Demencia asociada a intoxicación por paradiclorobencenoErwin Chiquete, MD, PhD
 
Spontaneous intracerebral hemorrhage in Mexico: results from a Multicenter Na...
Spontaneous intracerebral hemorrhage in Mexico: results from a Multicenter Na...Spontaneous intracerebral hemorrhage in Mexico: results from a Multicenter Na...
Spontaneous intracerebral hemorrhage in Mexico: results from a Multicenter Na...Erwin Chiquete, MD, PhD
 
Hemorragia intracerebral espontánea en México: resultados del Registro Hospit...
Hemorragia intracerebral espontánea en México: resultados del Registro Hospit...Hemorragia intracerebral espontánea en México: resultados del Registro Hospit...
Hemorragia intracerebral espontánea en México: resultados del Registro Hospit...Erwin Chiquete, MD, PhD
 
Presión arterial sistólica y pronóstico funcional en pacientes con enfermedad...
Presión arterial sistólica y pronóstico funcional en pacientes con enfermedad...Presión arterial sistólica y pronóstico funcional en pacientes con enfermedad...
Presión arterial sistólica y pronóstico funcional en pacientes con enfermedad...Erwin Chiquete, MD, PhD
 
Estudio multicéntrico INDAGA. Índice tobillo-brazo anormal en población mexic...
Estudio multicéntrico INDAGA. Índice tobillo-brazo anormal en población mexic...Estudio multicéntrico INDAGA. Índice tobillo-brazo anormal en población mexic...
Estudio multicéntrico INDAGA. Índice tobillo-brazo anormal en población mexic...Erwin Chiquete, MD, PhD
 

Más de Erwin Chiquete, MD, PhD (20)

Mortalidad asociada al diagnóstico de síndrome de Guillain-Barré en adultos i...
Mortalidad asociada al diagnóstico de síndrome de Guillain-Barré en adultos i...Mortalidad asociada al diagnóstico de síndrome de Guillain-Barré en adultos i...
Mortalidad asociada al diagnóstico de síndrome de Guillain-Barré en adultos i...
 
Seroepidemiology of Toxoplasma gondii infection in drivers involved in road t...
Seroepidemiology of Toxoplasma gondii infection in drivers involved in road t...Seroepidemiology of Toxoplasma gondii infection in drivers involved in road t...
Seroepidemiology of Toxoplasma gondii infection in drivers involved in road t...
 
Tiempo de llegada hospitalaria y pronóstico funcional después deun infarto ce...
Tiempo de llegada hospitalaria y pronóstico funcional después deun infarto ce...Tiempo de llegada hospitalaria y pronóstico funcional después deun infarto ce...
Tiempo de llegada hospitalaria y pronóstico funcional después deun infarto ce...
 
Comportamiento del barorreflejo en pacientes con síncope vasovagal durante el...
Comportamiento del barorreflejo en pacientes con síncope vasovagal durante el...Comportamiento del barorreflejo en pacientes con síncope vasovagal durante el...
Comportamiento del barorreflejo en pacientes con síncope vasovagal durante el...
 
Delírium en adultos que reciben cuidados paliativos: revisión de laliteratura...
Delírium en adultos que reciben cuidados paliativos: revisión de laliteratura...Delírium en adultos que reciben cuidados paliativos: revisión de laliteratura...
Delírium en adultos que reciben cuidados paliativos: revisión de laliteratura...
 
Massive Non-Encephalitic Neurocysticercosis
Massive Non-Encephalitic NeurocysticercosisMassive Non-Encephalitic Neurocysticercosis
Massive Non-Encephalitic Neurocysticercosis
 
Cost of care according to disease-modifying therapy in Mexicans with relapsin...
Cost of care according to disease-modifying therapy in Mexicans with relapsin...Cost of care according to disease-modifying therapy in Mexicans with relapsin...
Cost of care according to disease-modifying therapy in Mexicans with relapsin...
 
Blood pressure at hospital admission and outcome after primary intracerebral ...
Blood pressure at hospital admission and outcome after primary intracerebral ...Blood pressure at hospital admission and outcome after primary intracerebral ...
Blood pressure at hospital admission and outcome after primary intracerebral ...
 
Hepatitis C virus infection and type 2 diabetes mellitus in Mexican patients.
Hepatitis C virus infection and type 2 diabetes mellitus in Mexican patients. Hepatitis C virus infection and type 2 diabetes mellitus in Mexican patients.
Hepatitis C virus infection and type 2 diabetes mellitus in Mexican patients.
 
Atherothrombotic Disease, Traditional Risk Factors, and 4-Year Mortality in a...
Atherothrombotic Disease, Traditional Risk Factors, and 4-Year Mortality in a...Atherothrombotic Disease, Traditional Risk Factors, and 4-Year Mortality in a...
Atherothrombotic Disease, Traditional Risk Factors, and 4-Year Mortality in a...
 
Atypical forms of the osmotic demyelination syndrome
Atypical forms of the osmotic demyelination syndromeAtypical forms of the osmotic demyelination syndrome
Atypical forms of the osmotic demyelination syndrome
 
Spontaneous intracerebral hemorrhage in Mexico: results from a Multicenter Na...
Spontaneous intracerebral hemorrhage in Mexico: results from a Multicenter Na...Spontaneous intracerebral hemorrhage in Mexico: results from a Multicenter Na...
Spontaneous intracerebral hemorrhage in Mexico: results from a Multicenter Na...
 
An Expandable Prosthesis with Dual Cage-and-Plate Function in a Single Device...
An Expandable Prosthesis with Dual Cage-and-Plate Function in a Single Device...An Expandable Prosthesis with Dual Cage-and-Plate Function in a Single Device...
An Expandable Prosthesis with Dual Cage-and-Plate Function in a Single Device...
 
Expression profile of BRCA1 and BRCA2 genes in premenopausal Mexican women wi...
Expression profile of BRCA1 and BRCA2 genes in premenopausal Mexican women wi...Expression profile of BRCA1 and BRCA2 genes in premenopausal Mexican women wi...
Expression profile of BRCA1 and BRCA2 genes in premenopausal Mexican women wi...
 
31. cost of bc care
31. cost of bc care31. cost of bc care
31. cost of bc care
 
Demencia asociada a intoxicación por paradiclorobenceno
Demencia asociada a intoxicación por paradiclorobencenoDemencia asociada a intoxicación por paradiclorobenceno
Demencia asociada a intoxicación por paradiclorobenceno
 
Spontaneous intracerebral hemorrhage in Mexico: results from a Multicenter Na...
Spontaneous intracerebral hemorrhage in Mexico: results from a Multicenter Na...Spontaneous intracerebral hemorrhage in Mexico: results from a Multicenter Na...
Spontaneous intracerebral hemorrhage in Mexico: results from a Multicenter Na...
 
Hemorragia intracerebral espontánea en México: resultados del Registro Hospit...
Hemorragia intracerebral espontánea en México: resultados del Registro Hospit...Hemorragia intracerebral espontánea en México: resultados del Registro Hospit...
Hemorragia intracerebral espontánea en México: resultados del Registro Hospit...
 
Presión arterial sistólica y pronóstico funcional en pacientes con enfermedad...
Presión arterial sistólica y pronóstico funcional en pacientes con enfermedad...Presión arterial sistólica y pronóstico funcional en pacientes con enfermedad...
Presión arterial sistólica y pronóstico funcional en pacientes con enfermedad...
 
Estudio multicéntrico INDAGA. Índice tobillo-brazo anormal en población mexic...
Estudio multicéntrico INDAGA. Índice tobillo-brazo anormal en población mexic...Estudio multicéntrico INDAGA. Índice tobillo-brazo anormal en población mexic...
Estudio multicéntrico INDAGA. Índice tobillo-brazo anormal en población mexic...
 

Último

Neutraceuticals, Herb-drug & Herb-food inetractions
Neutraceuticals, Herb-drug & Herb-food inetractionsNeutraceuticals, Herb-drug & Herb-food inetractions
Neutraceuticals, Herb-drug & Herb-food inetractionsPradnya Wadekar
 
Neurological Evaluation of Acute Ischemic stroke in Emergency Room
Neurological Evaluation of Acute Ischemic stroke in Emergency RoomNeurological Evaluation of Acute Ischemic stroke in Emergency Room
Neurological Evaluation of Acute Ischemic stroke in Emergency RoomSudhir Kumar
 
Ortho Products Franchise-solace biotech limited
Ortho Products Franchise-solace biotech limitedOrtho Products Franchise-solace biotech limited
Ortho Products Franchise-solace biotech limitedSBL DIGITAL
 
HDT Unit 2: Nutraceuticals Global Market Overview And Growth Of Nutraceutical...
HDT Unit 2: Nutraceuticals Global Market Overview And Growth Of Nutraceutical...HDT Unit 2: Nutraceuticals Global Market Overview And Growth Of Nutraceutical...
HDT Unit 2: Nutraceuticals Global Market Overview And Growth Of Nutraceutical...Genesis Institute of Pharmacy, Radhanagari.
 
Range of Secondary Electrons and Electron Build-Up: Impact on Scatter in Homo...
Range of Secondary Electrons and Electron Build-Up: Impact on Scatter in Homo...Range of Secondary Electrons and Electron Build-Up: Impact on Scatter in Homo...
Range of Secondary Electrons and Electron Build-Up: Impact on Scatter in Homo...Dr. Dheeraj Kumar
 
Brief introduction to information ecosystem x public health.pptx
Brief introduction to information ecosystem x public health.pptxBrief introduction to information ecosystem x public health.pptx
Brief introduction to information ecosystem x public health.pptxTina Purnat
 
CELL BLOCK PREPARATION AND ITS IMPORTANCE
CELL BLOCK PREPARATION AND ITS IMPORTANCECELL BLOCK PREPARATION AND ITS IMPORTANCE
CELL BLOCK PREPARATION AND ITS IMPORTANCEShubhadip Ghosh
 
ANATOMY OF CEREBELLUM With Clinical Anatomy.pptx
ANATOMY OF CEREBELLUM With Clinical Anatomy.pptxANATOMY OF CEREBELLUM With Clinical Anatomy.pptx
ANATOMY OF CEREBELLUM With Clinical Anatomy.pptxsiddharthroy26587
 
Spinal cord Gross anatomy with Clinical Anatomy.pptx
Spinal cord Gross anatomy with Clinical Anatomy.pptxSpinal cord Gross anatomy with Clinical Anatomy.pptx
Spinal cord Gross anatomy with Clinical Anatomy.pptxsiddharthroy26587
 
Thyroid function tests for MBBS, LAB. MED & BDS.pptx
Thyroid function tests for MBBS, LAB. MED & BDS.pptxThyroid function tests for MBBS, LAB. MED & BDS.pptx
Thyroid function tests for MBBS, LAB. MED & BDS.pptxRajendra Dev Bhatt
 
TARGET DELINEATION IN CERVIX CANCER BY DR KANHU
TARGET DELINEATION IN CERVIX CANCER BY DR KANHUTARGET DELINEATION IN CERVIX CANCER BY DR KANHU
TARGET DELINEATION IN CERVIX CANCER BY DR KANHUKanhu Charan
 
Histology of lymph node(lymph node histology)
Histology of lymph node(lymph node histology)Histology of lymph node(lymph node histology)
Histology of lymph node(lymph node histology)pranavguleria2
 
HERPES SIMPLEX VIRUS 12032019 TUESDAY pptx
HERPES SIMPLEX VIRUS 12032019 TUESDAY  pptxHERPES SIMPLEX VIRUS 12032019 TUESDAY  pptx
HERPES SIMPLEX VIRUS 12032019 TUESDAY pptxPulkitMittal54
 
EMBRYOLOGY AND FOETAL DEVELOPMENT-mayu.pdf
EMBRYOLOGY AND FOETAL DEVELOPMENT-mayu.pdfEMBRYOLOGY AND FOETAL DEVELOPMENT-mayu.pdf
EMBRYOLOGY AND FOETAL DEVELOPMENT-mayu.pdfMayuriGamit2
 
Routine Medicine Laboratory Testing _ CÁC XÉT NGHIỆM THƯỜNG QUY ÁP DỤNG TRON...
Routine Medicine Laboratory Testing  _ CÁC XÉT NGHIỆM THƯỜNG QUY ÁP DỤNG TRON...Routine Medicine Laboratory Testing  _ CÁC XÉT NGHIỆM THƯỜNG QUY ÁP DỤNG TRON...
Routine Medicine Laboratory Testing _ CÁC XÉT NGHIỆM THƯỜNG QUY ÁP DỤNG TRON...DUY NGUYEN PHUC
 
SGK BỆNH LÝ GOUT YHN hay lắm nha aaaa.pdf
SGK BỆNH LÝ GOUT YHN hay lắm nha aaaa.pdfSGK BỆNH LÝ GOUT YHN hay lắm nha aaaa.pdf
SGK BỆNH LÝ GOUT YHN hay lắm nha aaaa.pdfHongBiThi1
 
SMA Implementation science seminar (Day 1).pptx
SMA Implementation science seminar (Day 1).pptxSMA Implementation science seminar (Day 1).pptx
SMA Implementation science seminar (Day 1).pptxAbdirahmanWaseem
 
TARGET DELINEATION IN RECTUM CANCER BY DR KANHU
TARGET DELINEATION IN RECTUM  CANCER BY DR KANHUTARGET DELINEATION IN RECTUM  CANCER BY DR KANHU
TARGET DELINEATION IN RECTUM CANCER BY DR KANHUKanhu Charan
 
Explaining "pathology" in digital pathology
Explaining "pathology" in digital pathologyExplaining "pathology" in digital pathology
Explaining "pathology" in digital pathologyYves Sucaet
 

Último (20)

Neutraceuticals, Herb-drug & Herb-food inetractions
Neutraceuticals, Herb-drug & Herb-food inetractionsNeutraceuticals, Herb-drug & Herb-food inetractions
Neutraceuticals, Herb-drug & Herb-food inetractions
 
Neurological Evaluation of Acute Ischemic stroke in Emergency Room
Neurological Evaluation of Acute Ischemic stroke in Emergency RoomNeurological Evaluation of Acute Ischemic stroke in Emergency Room
Neurological Evaluation of Acute Ischemic stroke in Emergency Room
 
Ortho Products Franchise-solace biotech limited
Ortho Products Franchise-solace biotech limitedOrtho Products Franchise-solace biotech limited
Ortho Products Franchise-solace biotech limited
 
HDT Unit 2: Nutraceuticals Global Market Overview And Growth Of Nutraceutical...
HDT Unit 2: Nutraceuticals Global Market Overview And Growth Of Nutraceutical...HDT Unit 2: Nutraceuticals Global Market Overview And Growth Of Nutraceutical...
HDT Unit 2: Nutraceuticals Global Market Overview And Growth Of Nutraceutical...
 
Range of Secondary Electrons and Electron Build-Up: Impact on Scatter in Homo...
Range of Secondary Electrons and Electron Build-Up: Impact on Scatter in Homo...Range of Secondary Electrons and Electron Build-Up: Impact on Scatter in Homo...
Range of Secondary Electrons and Electron Build-Up: Impact on Scatter in Homo...
 
Oral disorders .pptx
Oral disorders .pptxOral disorders .pptx
Oral disorders .pptx
 
Brief introduction to information ecosystem x public health.pptx
Brief introduction to information ecosystem x public health.pptxBrief introduction to information ecosystem x public health.pptx
Brief introduction to information ecosystem x public health.pptx
 
CELL BLOCK PREPARATION AND ITS IMPORTANCE
CELL BLOCK PREPARATION AND ITS IMPORTANCECELL BLOCK PREPARATION AND ITS IMPORTANCE
CELL BLOCK PREPARATION AND ITS IMPORTANCE
 
ANATOMY OF CEREBELLUM With Clinical Anatomy.pptx
ANATOMY OF CEREBELLUM With Clinical Anatomy.pptxANATOMY OF CEREBELLUM With Clinical Anatomy.pptx
ANATOMY OF CEREBELLUM With Clinical Anatomy.pptx
 
Spinal cord Gross anatomy with Clinical Anatomy.pptx
Spinal cord Gross anatomy with Clinical Anatomy.pptxSpinal cord Gross anatomy with Clinical Anatomy.pptx
Spinal cord Gross anatomy with Clinical Anatomy.pptx
 
Thyroid function tests for MBBS, LAB. MED & BDS.pptx
Thyroid function tests for MBBS, LAB. MED & BDS.pptxThyroid function tests for MBBS, LAB. MED & BDS.pptx
Thyroid function tests for MBBS, LAB. MED & BDS.pptx
 
TARGET DELINEATION IN CERVIX CANCER BY DR KANHU
TARGET DELINEATION IN CERVIX CANCER BY DR KANHUTARGET DELINEATION IN CERVIX CANCER BY DR KANHU
TARGET DELINEATION IN CERVIX CANCER BY DR KANHU
 
Histology of lymph node(lymph node histology)
Histology of lymph node(lymph node histology)Histology of lymph node(lymph node histology)
Histology of lymph node(lymph node histology)
 
HERPES SIMPLEX VIRUS 12032019 TUESDAY pptx
HERPES SIMPLEX VIRUS 12032019 TUESDAY  pptxHERPES SIMPLEX VIRUS 12032019 TUESDAY  pptx
HERPES SIMPLEX VIRUS 12032019 TUESDAY pptx
 
EMBRYOLOGY AND FOETAL DEVELOPMENT-mayu.pdf
EMBRYOLOGY AND FOETAL DEVELOPMENT-mayu.pdfEMBRYOLOGY AND FOETAL DEVELOPMENT-mayu.pdf
EMBRYOLOGY AND FOETAL DEVELOPMENT-mayu.pdf
 
Routine Medicine Laboratory Testing _ CÁC XÉT NGHIỆM THƯỜNG QUY ÁP DỤNG TRON...
Routine Medicine Laboratory Testing  _ CÁC XÉT NGHIỆM THƯỜNG QUY ÁP DỤNG TRON...Routine Medicine Laboratory Testing  _ CÁC XÉT NGHIỆM THƯỜNG QUY ÁP DỤNG TRON...
Routine Medicine Laboratory Testing _ CÁC XÉT NGHIỆM THƯỜNG QUY ÁP DỤNG TRON...
 
SGK BỆNH LÝ GOUT YHN hay lắm nha aaaa.pdf
SGK BỆNH LÝ GOUT YHN hay lắm nha aaaa.pdfSGK BỆNH LÝ GOUT YHN hay lắm nha aaaa.pdf
SGK BỆNH LÝ GOUT YHN hay lắm nha aaaa.pdf
 
SMA Implementation science seminar (Day 1).pptx
SMA Implementation science seminar (Day 1).pptxSMA Implementation science seminar (Day 1).pptx
SMA Implementation science seminar (Day 1).pptx
 
TARGET DELINEATION IN RECTUM CANCER BY DR KANHU
TARGET DELINEATION IN RECTUM  CANCER BY DR KANHUTARGET DELINEATION IN RECTUM  CANCER BY DR KANHU
TARGET DELINEATION IN RECTUM CANCER BY DR KANHU
 
Explaining "pathology" in digital pathology
Explaining "pathology" in digital pathologyExplaining "pathology" in digital pathology
Explaining "pathology" in digital pathology
 

Central Adiposity and Mortality after First-Ever Acute Ischemic Stroke

  • 1. Original Paper Received: February 15, 2013 Accepted: March 18, 2013 Published online: July 13, 2013 Eur Neurol 2013;70:117–123 DOI: 10.1159/000350762 Central Adiposity and Mortality after First-Ever Acute Ischemic Stroke Erwin Chiquete a José L. Ruiz-Sandoval c Luis Murillo-Bonilla e Carolina León-Jiménez g Bertha Ruiz-Madrigal d, f Erika Martínez-López d, f Sonia Román d, f Arturo Panduro d, f Alma Ramos b Carlos Cantú-Brito a             a         Department of Neurology and Psychiatry, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, and Scientific Area, Sanofi-Aventis, Mexico City, Departments of c Neurology and d Molecular Biology, Hospital Civil de Guadalajara ‘Fray Antonio Alcalde’, e Departments of Neurology, Facultad de Medicina, Universidad Autónoma de Guadalajara, and f Department of Molecular Biology, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara, and g Department of Neurology, Hospital Valentín Gomez Farías, Zapopan, Mexico   b             Abstract Background: The waist-to-height ratio (WHtR) may be a better adiposity measure than the body mass index (BMI). We evaluated the prognostic performance of WHtR in patients with acute ischemic stroke (AIS). Methods: First, we compared WHtR and BMI as adiposity measures in 712 healthy adults by tetrapolar bioimpedance analysis. Thereafter, baseline WHtR was analyzed as predictor of 12-month allcause mortality in 821 Mexican mestizo adults with first-ever AIS by a Cox proportional hazards model adjusted for baseline predictors. Results: In healthy individuals, WHtR correlated higher than BMI with total fat mass and showed a higher accuracy in identifying a high percentage of body fat (p < 0.01). In AIS patients a U-shaped relationship was observed between baseline WHtR and mortality (fatality rate 29.1%). On multivariate analysis, baseline WHtR ≤0.300 or >0.800 independently predicted 12-month all-cause mortality (hazard ratio 1.91, 95% confidence interval 1.04–3.51). BMI was © 2013 S. Karger AG, Basel 0014–3022/13/0702–0117$38.00/0 E-Mail karger@karger.com www.karger.com/ene not associated with mortality, tested either as continuous, binomial or stratified variable. Conclusion: WHtR is a modifiable risk factor that accurately demonstrates body fat excess. Extreme WHtR values were associated with increased 12-month all-cause mortality in Mexican mestizo patients with AIS. No survival advantage was found with high WHtR as the pragmatic indicator of obesity in this population. Copyright © 2013 S. Karger AG, Basel Introduction Obesity is a well-recognized risk factor for acute ischemic stroke (AIS) [1, 2], however when BMI is tested as predictor of mortality in people with atherothrombotic complications such as myocardial infarction, stroke or heart failure, a high body mass index (BMI) has been associated with a survival advantage (the so-called obesity paradox) [3–6]. BMI is an index of both lean and fat tissues (i.e. total body mass) as a function of height squared and therefore BMI is not the ideal indicator of obesity [7, 8]. Other anthropometric measures, such as the waist-to-height ratio Dr. Carlos Cantú-Brito Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán Vasco de Quiroga 15 Tlalpan, Mexico City, CP 14439 (Mexico) E-Mail carloscantu_brito @ hotmail.com Downloaded by: 201.141.112.10 - 7/25/2013 1:35:20 PM Key Words Adiposity · Body composition · Body fat · Body mass index · Obesity paradox · Overweight · Stroke
  • 2. Methods We compared WHtR, BMI and other anthropometric measures as references of body adiposity in healthy adults in order to find the best adiposity index of general adiposity that can be applied in AIS patients to evaluate whether the excessive body fat is a predictor of 12-month all-cause mortality. To find the best anthropometric measure of body adiposity, a total of 712 Mexican mestizo adults without a history of stroke were invited to receive body composition evaluation at the Department of Molecular Biology in Medicine, Hospital Civil de Guadalajara ‘Fray Antonio Alcalde’, Guadalajara, Mexico. The institutional committee of ethics of the Hospital Civil de Guadalajara approved this part of the study. Informed consent was required for all subjects. These individuals underwent evaluation by means of bioimpedance analysis (BIA) with a computerized multifrequency tetrapolar 8-point tactile electrode BIA system (Inbody 720; analyzing software: Inbody 3.0; Biospace Co., Ltd, Seoul, Korea). Participating subjects were evaluated in the morning, with cotton underwear without metal or synthetic textiles, in overnight fasting and having evacuated bladder and rectum. The individuals were asked to remove their clothes, excepting underwear, and they were provided with a disposable cotton-made coat for use during BIA. Hands and soles were cleaned up and impregnated with an electrolyte solution. BMI was calculated as weight (kg) divided by height (m). WHtR was calculated as waist circumference (WC) (cm) divided by height (cm), by using the waist measurement of the narrowest point between the lower costal border and the top of the iliac crest. Waist-to-hip ratio (WHR) was calculated as WC (cm) divided by the hip circumference (cm). Body fat and lean mass content were estimated by using the standard built-in prediction algorithms for adults (Biospace Co., Ltd.). Among 1,376 participants with AIS or transient ischemic attack (TIA) registered in the PREMIER study [8, 10–12], a total of 821 first-ever AIS patients with complete anthropometric evaluations and 12-month follow-up outcome information were selected for this part of the study. TIA cases were not included in this analysis. A central institutional review board and the local committee of ethics of each participating center approved the study. In brief, consecutive patients with AIS or TIA aged ≥18 years were included. All patients received medical care within 7 days of AIS onset. Data collection was prospectively performed during 1 year (in six planned research visits) by using a standardized structured questionnaire outlined in a procedure manual. All participating physicians were instructed on stroke guidelines, classification and management. Stroke subtypes were registered according to Trial of ORG 10172 in Acute Stroke (TOAST) and Oxfordshire Community Stroke Project (OCSP) classifications. AIS severity was assessed by the National Institutes of Health Stroke Scale (NIHSS) at 118 Eur Neurol 2013;70:117–123 DOI: 10.1159/000350762 baseline, and the modified Rankin scale (mRS) was used to evaluate the functional outcome at hospital discharge, 30 and 90 days, 6, and 12 months after AIS (the six research visits). Weight, height, and WC were measured at baseline by direct assessment with scales, stadiometer or flexible metric rulers, with standard procedures for either supine or stand-up positions, as corresponded. Hip circumference was not measured in this cohort. BMI and WHtR were calculated as described above. The investigator ascertained every fatality case either directly during hospitalization, or at each follow-up visit by telephone interview with caregivers. The exact day of death was recorded. The information of the standardized structured questionnaires was saved on independent electronic files in data capture software developed and revised periodically by a contract research organization (CRO; Innoval Co.). Members of the CRO analyzed information on every patient for completeness and plausibility. Missing or implausible variables were referred to the investigator for clarification. Data quality was ascertained by periodic statistical reports and clinical site visits by CRO monitors. Parametric continuous variables are expressed as geometric means and standard deviations (SD), or minimum and maximum. Non-parametric continuous variables are expressed as medians and interquartile range (IQR). Categorical variables are expressed as percentages. To compare quantitative variables distributed between two groups, Student’s t test and Mann-Whitney U test were performed in distributions of parametric and nonparametric variables, respectively. χ2 statistics were used to compare nominal variables in bivariate analyses. Pearson’s ρ correlation was used to test the continuous association between two quantitative variables. An r-to-z transformation was performed to calculate a ‘z’ score that can be applied to assess the significance of the difference between two correlation coefficients. Different WHtR, BMI cutoffs, NIHSS cutoffs, and demographic as well as clinical variables were tested as predictors of 12-month all-cause mortality in univariate analyses. Variables significantly associated with mortality were selected to integrate a multivariate prediction model. Kaplan-Meyer survival estimates and Cox proportional hazards models at 12-month follow-up were constructed to find independent baseline risk factors for all-cause mortality after AIS, testing the WHtR and BMI cutoffs selected in univariate analyses. Multivariate hazard ratios (HR) and their respective 95% confidence intervals (CI) are provided. In healthy subjects, BMI, WC and WHtR were evaluated by a receiver-operating characteristic (ROC) curve for discrimination of a percentage of body fat (%BF) >20 and >30, regarding as superior the index with the largest area under the curve (AUC) without overlapping 95% CIs. All p values are two-sided and considered significant when p < 0.05. SPSS version 17.0 software was used for all statistical calculations. Results WHtR Is Better than BMI as an Index of Adiposity A total of 712 healthy adults (mean age 38.2, median 38, IQR 28–45 years; 60.5% women) underwent BIA for body composition assessment. Significant differences were observed between men and women with respect to Chiquete  et al.   Downloaded by: 201.141.112.10 - 7/25/2013 1:35:20 PM (WHtR), may denote more precisely the excess of body adiposity [9]. Growing evidence suggests that WHtR is stronger than BMI as a risk factor for stroke [2]. In this study we tested the hypotheses that WHtR is better than BMI as an index of adiposity in healthy adults and stronger than BMI as predictor of death in Mexican patients with a first-ever AIS.
  • 3. Color version available online 80 60 40 AUC (95% CI) WHtR: 0.908 (0.883–0.932) BMI: 0.769 (0.729–0.810) WC: 0.808 (0.771–0.845) WHR: 0.775 (0.734–0.816) 20 0 0 a 20 40 60 80 100 False positives (%) True positives (%) 100 80 True positives (%) 100 60 40 AUC (95% CI) WHtR: 0.961 (0.949–0.973) BMI: 0.889 (0.866–0.912) WC: 0.907 (0.886–0.928) WHR: 0.842 (0.812–0.872) 20 0 0 20 b 40 60 80 100 False positives (%) Mexican mestizo adults who underwent tetrapolar BIA. b ROC curve on the discriminatory function of anthropometric indices for %BF >30. Table 1. Univariate Pearson’s correlation of several indices of adi- mean %BF (27.7 vs. 31.8%, respectively; p < 0.001), BMI (28.5 vs. 25.9, respectively; p < 0.001), WC (93.6 vs. 89.3 cm, respectively; p = 0.001) and WHR (0.880 vs. 0.890, respectively; p = 0.03), but not with respect to age (38.6 vs. 38.0 years, respectively; p = 0.52) or, more importantly, the WHtR (0.550 vs. 0.560, respectively; p = 0.53). In healthy adults, WHtR correlated significantly higher than  BMI with total body fat within each BMI interval (table 1). Moreover, WHtR showed higher accuracy than BMI, WC or WHR in identifying both a %BF >20 or >30 (fig. 1a, b). WHtR Is a Predictor of 12-Month All-Cause Mortality after a First-Ever AIS A total of 821 Mexican mestizo patients with AIS (52.6% women, mean age 67.9, median 70, IQR 57–79 years) were analyzed for the association of baseline adiposity measures with 12-month all-cause mortality (table  2). At the 12-month follow-up, a total of 90 (11.0%) patients achieved a mRS = 0; 191 (23.3%) had a mRS = 1; 109 (13.3%) had a mRS = 2; 89 (10.8%) had a mRS = 3; 74 (9.0) had a mRS = 4; 29 (3.5%) had a mRS = 5, and 239 (29.1%) patients died. A U-shaped relationship was observed between WHtR intervals and 12-month all-cause mortality risk (fig. 2a), so that both low or high baseline WHtR measurements were associated with an increased 12-month mortality rate. Notably, mean BMI increased as a function of WHtR, but BMI ranges significantly overlapped across WHtR intervals (fig. 2a). An inverse relationship was found between the frequency of hypercholesterolemia and 12-month allcause mortality (table 2), possibly explained by the higher use of statins among patients with dyslipidemia than among non-dyslipidemic individuals (9.1 vs. 5.2%, respectively; p = 0.04). Kaplan-Meier estimates showed a significantly lower survival in patients with baseline WHtR ≤0.300 or >0.800 (fig. 2b). Differences in mortality rates were significant since the first 6 months after AIS (p = 0.03). In a multivariate analysis by the Cox proportional hazards method adjusted for relevant baseline confounders (table 3), WHtR ≤0.300 or >0.800, age >65 years, to- Central Adiposity and Mortality in Acute Stroke Eur Neurol 2013;70:117–123 DOI: 10.1159/000350762 posity with %BF, according to BMI strata, in 712 healthy adults who received tetrapolar BIAa Characteristic BMI <20 BMI 20–25 BMI 25.1–30 BMI >30 (n = 48) (n = 285) (n = 197) (n = 182) WHtR BMI WC WHR 0.773b 0.401b 0.614b 0.597b 0.702b 0.237b 0.396b 0.355b 0.864b 0.460b 0.557b 0.530b –0.715b –0.666b –0.423b –0.026 a p < 0.05 for comparison of Pearson’s correlation between BMI and total body fat with that of WHtR and total body fat. b p < 0.001 for significance of univariate Pearson’s correlation. 119 Downloaded by: 201.141.112.10 - 7/25/2013 1:35:20 PM Fig. 1. Accuracy of anthropometric measures in identifying excessive adiposity in healthy adults. a ROC curve on the discriminatory function of anthropometric indices for %BF >20 in 712 healthy
  • 4. Table 2. Main characteristics of patients with a first-ever acute cerebral infarction (n = 821) and their association with 12-month allcause mortality Variable 12-Month all-cause mortality absent (n = 582) Median age, years Male NIHSS at hospital admission, median Major vascular risk factors Hypertension Diabetes mellitus Hypercholesterolemia Atrial fibrillation Coronary artery disease Heart failure Past or current smoking Ischemic stroke syndromes Total anterior circulation cerebral infarction Partial anterior circulation cerebral infarction Lacunar cerebral infarction Posterior circulation cerebral infarction Ischemic stroke mechanisms Large-artery atherothrombosis Lacunar Cardioembolism Mixed mechanism Other determined mechanisms Undetermined mechanism Baseline anthropometric measures Weight, kg Height, m WC, cm WHtR Body mass index >25 >27 >30 >35 68.0 [56.0–77.0] 282 (48.5) 8.0 [5.0–13.0] p value present (n = 239) 77.00 [65.0–85.0] 107 (44.8) 19.0 [14.0–26.5] 373 (64.1) 199 (34.2) 136 (23.4) 44 (7.6) 70 (12.0) 40 (6.9) 212 (36.4) 157 (65.7) 84 (35.1) 29 (12.1) 46 (19.2) 36 (15.1) 38 (15.9) 93 (38.9) 54 (9.3) 238 (40.9) 190 (32.6) 100 (17.2) 119 (49.8) 72 (30.1) 13 (5.4) 35 (14.6) 56 (9.6) 140 (24.1) 91 (15.6) 33 (5.7) 35 (6.0) 227 (39.0) 9 (3.8) 12 (5.0) 65 (27.2) 12 (5.0) 9 (3.8) 132 (55.2) 71.8±4.6 1.62±0.09 93.3±15.4 0.577±0.096 27.35±4.66 406 (69.8) 290 (49.8) 138 (23.7) 30 (5.2) 70.4±15.3 1.61±0.09 93.7±17.4 0.584±0.105 27.19±5.20 153 (64.0) 120 (50.2) 62 (25.9) 15 (6.3) <0.001 <0.34 <0.001 <0.66 <0.79 <0.001 <0.001 <0.24 <0.001 <0.50 <0.001 <0.001 <0.19 <0.10 <0.75 <0.41 <0.67 <0.11 <0.92 <0.50 <0.52 Values are mean ± SD, n (%) or IQR in brackets. Discussion When compared with BMI these results demonstrate that WHtR is a better measure of adiposity and a stronger predictor of 12-month all-cause mortality in Mexican 120 Eur Neurol 2013;70:117–123 DOI: 10.1159/000350762 mestizo patients with AIS. We found a U-shaped relationship between WHtR and mortality, and therefore did not observe any protective effect of a high BMI or high WHtR in this first-ever AIS cohort. WHtR has been traditionally considered an anthropometric measure of central adiposity adjusted for a given height [7, 9]. Here we show that WHtR can accurately indicate general adiposity as well. Central adiposity has been found to be associated with an adverse metabolic profile that traduce into a high cardiovascular risk [9]. If WC parallels with increments of visceral fat tissue when weight gain occurs at the expense of positive energy balChiquete  et al.   Downloaded by: 201.141.112.10 - 7/25/2013 1:35:20 PM tal anterior circulation cerebral infarction syndrome, and NIHSS were significant predictors of 12-month all-cause mortality (table  3). BMI was not significantly associated with 12-month mortality, tested either as a continuous, binomial or stratified variable (table 3).
  • 5. 2 20 0 0 Deaths, n Number at risk a BMI Mean SD Range 100 80 WHtR 0.301–0.800 60 40 WHtR 20 Fig. 2. All-cause mortality after a first-ever AIS. a One-year all-cause mortality ac- cording to baseline WHtR: in circles, relative frequency; in triangles, age- and sexadjusted HRs. The corresponding BMI for every WHtR interval is also shown. b Kaplan-Meier estimates according to baseline WHtR ≤0.300 or >0.800. Rhombuses indicate censored cases. 0 Number at risk WHtR 0.301–0.800 b WHtR 0 802 19 100 200 300 Days after first-ever AIS 614 11 593 10 400 570 8 As reflected by WHtR, in the present study both a reduced and an excessive central adiposity increase the probability of death after a first-ever cerebral infarction. Indeed, on the one hand it is possible that certain energy stores are necessary to cope with metabolic demands that follow AIS [8, 13, 14], and on the other hand, an excessive visceral fat could be associated with an adverse risk profile. When analyzing a high BMI as a predictor of mortality in subjects who have survived an atherothrombotic Central Adiposity and Mortality in Acute Stroke Eur Neurol 2013;70:117–123 DOI: 10.1159/000350762 121 Downloaded by: 201.141.112.10 - 7/25/2013 1:35:20 PM ance, then WHtR may denote more accurately the most important body mass in terms of chronic risks. Both obese and muscled persons can have the same BMI if weight (with different proportions of lean and fat masses) and height are the same, but with radically different risks. On the other hand, WC does not increase significantly in muscled individuals; hence, the adjustment of WC for height provides the opportunity of correcting central adiposity for variations of height.
  • 6. Table 3. Multivariate analysis on baseline factors associated with 12-month all-cause mortality in patients with a first-ever acute cerebral infarction (n = 821): a Cox proportional hazards modela Predictor HR (95% CI) p value TACI NIHSSb WHtR ≤0.300 or >0.800 Agec 2.435 (1.759−3.371) 2.182 (1.751−2.720) 1.911 (1.040−3.514) 1.018 (1.008−1.027) <0.001 <0.001 <0.037 <0.001 a   Adjusted for atrial fibrillation, hypercholesterolemia, statin use, heart failure, stroke mechanisms, stroke syndromes, BMI (tested as a continuous, stratified or binomial variable with different cutoffs), WC and total body weight. b  NIHSS <9, 9–18 and >18 points. c  Age per 1-year increment. complication (i.e. stroke, myocardial infarction, heart failure, and other complications), it can be erroneously concluded that obesity provides a survival advantage, a concept that may be misinterpreted by the general population, with potential negative consequences for public health. Our findings are in conflict with the obesity paradox concept. In a previous analysis of the PREMIER cohort, we originally found that a high BMI was apparently associated with a good functional outcome in stroke survivors exclusively [8], confirming the obesity paradox in the context of functional recovery. However, when WHtR was analyzed as a measure of adiposity excess (i.e. obesity), no functional advantage was found with high WHtR or high BMI in adjusted multivariate analyses [8]. It is possible that the elimination of patients with a previous stroke can reduce the bias of survival selection for the obese individuals, then reducing the apparent advantage with high BMI values. In other words, it remains unquestionable that a high BMI is strongly associated with increased mortality and cardiovascular risks [15–17], but when studying persons who already have a cardiovascular event, and the onset of such an event is the new ‘zero point’ for mortality analysis, the inclusion of obese patients who had survived several cardiovascular events may bias towards the selection of strong body constitutions that may be more ‘resistant’ to the metabolic challenges after atherothrombotic events in the long run. So far, no indisputable explanation to the obesity paradox concept has been put forward [18]. The main limitation of our study is the lack of direct body composition analysis in the cohort with AIS, which would allow for estimation of the exact predictive value of adiposity in diseased persons. Another limitation is the relatively small sample size that might hamper robust analyses. At the population level different WHtR cutoffs may apply in terms of long-term cardiometabolic risks, if we consider that the present study was only about patients with arterial disease at baseline. Given the body composition characteristics of the Mexican mestizo population, our findings should be tested in different bioethnic groups and other forms of cerebrovascular and cardiometabolic diseases. In conclusion, extreme WHtR values are modestly, but significantly associated with an increased all-cause mortality risk in Mexican mestizos, in the late part of the evolution after a first-ever AIS. These findings should be retested in different scenarios. Disclosure Statement This study received unrestricted funds from Sanofi-Aventis for the registering of patients with stroke. The company did not participate, either directly or indirectly in study design, selection of patients, data analysis, manuscript draft or the decision to summit for publication. Mrs. A. Ramos is employed by Sanofi-Aventis, Mexico, in the Clinical Research Area, and Dr. C. Cantú-Brito served in the Scientific Advisory Board of the PREMIER Registry. None of the other authors have any conflicts of interest to disclose. References 122 risk of stroke: the MOnica Risk, Genetics, Archiving and Monograph (MORGAM) study. Stroke 2011;42:2872–2877. 3 Gruberg L, Weissman NJ, Waksman R, Fuchs S, Deible R, Pinnow EE, Ahmed LM, Kent KM, Pichard AD, Suddath WO, Satler LF, Lindsay J Jr: The impact of obesity on the short-term and long-term outcomes after percutaneous coronary intervention: the obesity paradox? J Am Coll Cardiol 2002;39:578–584. Eur Neurol 2013;70:117–123 DOI: 10.1159/000350762 4 Curtis JP, Selter JG, Wang Y, Rathore SS, Jovin IS, Jadbabaie F, Kosiborod M, Portnay EL, Sokol SI, Bader F, Krumholz HM: The obesity paradox: body mass index and outcomes in patients with heart failure. Arch Intern Med 2005;165:55–61. 5 Kim BJ, Lee SH, Ryu WS, Kim CK, Lee J, Yoon BW: Paradoxical longevity in obese patients with intracerebral hemorrhage. Neurology 2011;76:567–573. Chiquete  et al.   Downloaded by: 201.141.112.10 - 7/25/2013 1:35:20 PM 1 Oki I, Nakamura Y, Okamura T, Okayama A, Hayakawa T, Kita Y, Ueshima H: Nippon Data80 Research Group: Body mass index and risk of stroke mortality among a random sample of Japanese adults: 19-year follow-up of NIPPON DATA80. Cerebrovasc Dis 2006;22:409–415. 2 Bodenant M, Kuulasmaa K, Wagner A, Kee F, Palmieri L, Ferrario MM, Montaye M, Amouyel P, Dallongeville J: MORGAM Project: measures of abdominal adiposity and the
  • 7. Central Adiposity and Mortality in Acute Stroke 10 Cantú-Brito C, Ruiz-Sandoval JL, MurilloBonilla LM, Chiquete E, León-Jiménez C, Arauz A, Villarreal-Careaga J, Barinagarrementeria F, Ramos-Moreno A; PREMIER Investigators: The first Mexican multicenter register on ischaemic stroke (the PREMIER study): demographics, risk factors and outcome. Int J Stroke 2011;6:93–94. 11 Cantú-Brito C, Ruiz-Sandoval JL, MurilloBonilla LM, Chiquete E, León-Jiménez C, Arauz A, Villarreal-Careaga J, Barinagarrementeria F, Ramos-Moreno A; PREMIER Investigators: Acute care and one-year outcome of Mexican patients with first-ever acute ischemic stroke: the PREMIER study. Rev Neurol 2010;51:641–649. 12 Chiquete E, Ruiz-Sandoval JL, Murillo-Bonilla LM, Arauz-Góngora A, Ochoa-Guzmán A, Villarreal-Careaga J, León-Jiménez C, Barinagarrementeria F, Ramos-Moreno A, Cantú-Brito C: Serum uric acid and outcome after acute ischemic stroke: PREMIER study. Cerebrovasc Dis 2013;35:168–174. 13 Koton S, Molshatzki N, Bornstein NM, Tanne D: Low cholesterol, statins and outcomes in patients with first-ever acute ischemic stroke. Cerebrovasc Dis 2012;34:213–220. 14 Ryu WS, Lee SH, Kim CK, Kim BJ, Yoon BW: Body mass index, initial neurological severity and long-term mortality in ischemic stroke. Cerebrovasc Dis 2011;32:170–176. 15 Calle EE, Thun MJ, Petrelli JM, Rodriguez C, Heath CW Jr: Body mass index and mortality in a prospective cohort of US adults. N Engl J Med 1999;341:1097–1105. 16 Jee SH, Sull JW, Park J, Lee SY, Ohrr H, Guallar E, Samet JM: Body mass index and mortality in Korean men and women. N Engl J Med 2006;355:779–787. 17 Pischon T, Boeing H, Hoffmann K, Bergmann M, Schulze MB, Overvad K: General and abdominal adiposity and risk of death in Europe. N Engl J Med 2008; 359: 2105–2120. Erratum in: N Engl J Med 2010;362:2433. 18 Chrysant SG, Chrysant GS: New insights into the true nature of the obesity paradox and the lower cardiovascular risk. J Am Soc Hypertens 2013;7:85–94. Eur Neurol 2013;70:117–123 DOI: 10.1159/000350762 123 Downloaded by: 201.141.112.10 - 7/25/2013 1:35:20 PM 6 Vemmos K, Ntaios G, Spengos K, Savvari P, Vemmou A, Pappa T, Manios E, Georgiopoulos G, Alevizaki M: Association between obesity and mortality after acute first-ever stroke: the obesity-stroke paradox. Stroke 2011; 42: 30–36. 7 Lee K, Song YM, Sung J: Which obesity indicators are better predictors of metabolic risk? Healthy twin study. Obesity (Silver Spring) 2008;16:834–840. 8 Chiquete E, Cantú-Brito C, Villarreal-Careaga J, Murillo-Bonilla LM, Rangel-Guerra R, LeónJiménez C, Ochoa-Guzmán A, Ramos-Moreno A, Arauz A, Barinagarrementeria F, Panduro A, Ruiz-Sandoval JL: Obesity paradox and functional recovery in first-ever acute ischemic stroke survivors: the PREMIER study (in Spanish). Rev Neurol 2010;51:705–713. 9 Ashwell M, Gunn P, Gibson S: Waist-toheight ratio is a better screening tool than waist circumference and BMI for adult cardiometabolic risk factors: systematic review and meta-analysis. Obes Rev 2012; 13: 275– 286.